Full Deposit on Sale of O'Riordan Property
|
30 June 2023 at 4:05pm
|
Completion of Bourke Road Sale
|
30 May 2023 at 8:55am
|
Appendix 3Z Daniela Fontana
|
1 May 2023 at 1:30pm
|
Director Appointment/Resignation
|
27 April 2023 at 4:30pm
|
Change in substantial holding
|
3 April 2023 at 5:05pm
|
A2B agrees to sale of O'Riordan Street, Alexandria
|
30 March 2023 at 5:30pm
|
Daniela Fontana - Initial Director's Interest Notice
|
3 March 2023 at 9:15am
|
H1 FY 23 Accounts Presentation
|
21 February 2023 at 8:45am
|
Half Year Accounts Announcement 1H23
|
21 February 2023 at 8:45am
|
Half Yearly Report and Accounts
|
21 February 2023 at 8:45am
|
A2B H1FY23 Results Date and Briefing Details
|
7 February 2023 at 10:25am
|
General Counsel and Company Secretary Change
|
23 January 2023 at 9:50am
|
Change in substantial holding from SNC
|
5 January 2023 at 5:40pm
|
A2B agrees to sale of 9-13 Bourke Road, Alexandria
|
20 December 2022 at 5:15pm
|
Results of Annual General Meeting 2022
|
17 November 2022 at 1:50pm
|
Executive Chairman's Address to Shareholders
|
17 November 2022 at 10:10am
|
CEO Appointment and Trading Update
|
3 November 2022 at 8:40am
|
Change in substantial holding from SNC
|
18 October 2022 at 4:10pm
|
Notice of 2022 A2B Annual General Meeting & Proxy Form
|
14 October 2022 at 9:55am
|
Brent Cubis - Initial Director's Interest Notice
|
6 October 2022 at 10:05am
|
David Grant - Final Director's Interest Notice
|
6 October 2022 at 10:00am
|
Director Appointment/Resignation
|
26 September 2022 at 10:05am
|
J Horrigan - Change of Director's Interest Notice
|
19 September 2022 at 1:00pm
|
J Horrigan - Change of Director's Interest Notice
|
15 September 2022 at 11:45am
|
Executive Chairman Contract Extension
|
8 September 2022 at 10:05am
|
J Horrigan - Change of Director's Interest Notice
|
5 September 2022 at 10:00am
|
2022 Corporate Governance Statement and Appendix 4G
|
23 August 2022 at 8:55am
|
FY22 Results Investor Deck
|
23 August 2022 at 8:55am
|
FY22 Results Announcement
|
23 August 2022 at 8:55am
|
2022 Appendix 4E and Annual Report to shareholders
|
23 August 2022 at 8:55am
|
Timing of release and investor call details for FY22 results
|
10 August 2022 at 10:10am
|
Strategic Review Update -14 July 2022
|
14 July 2022 at 2:00pm
|
Change in substantial holding from SNC
|
6 July 2022 at 3:50pm
|
A2B Investor Day - 14 July 2022
|
30 June 2022 at 10:05am
|
Notification regarding unquoted securities - A2B
|
5 May 2022 at 4:35pm
|
Application for quotation of securities - A2B
|
5 May 2022 at 4:25pm
|
Results of EGM and Appendix 3X
|
28 April 2022 at 1:55pm
|
Chairman's Address to Shareholders
|
28 April 2022 at 10:25am
|
Notice of Extraordinary General Meeting/Proxy Form
|
29 March 2022 at 10:15am
|
Final Director's Interest Notice - Louise McCann
|
22 March 2022 at 5:10pm
|
Final Director's Interest Notice - Louise McCann
|
22 March 2022 at 10:30am
|
Appointment of Mark Bayliss and Retirement of Louise McCann
|
2 March 2022 at 8:55am
|
1H22 Results Announcement
|
25 February 2022 at 8:40am
|
1H22 Results Presentation
|
25 February 2022 at 8:35am
|
Half Yearly Report and Accounts
|
25 February 2022 at 8:35am
|
Appendix 3Z - Andrew Skelton
|
11 February 2022 at 10:55am
|
Appendix 3Z - Paul Oneile
|
10 February 2022 at 4:25pm
|
Change in substantial holding from SNC
|
8 February 2022 at 2:40pm
|
A2B Leadership Change and Strategic Review
|
8 February 2022 at 10:05am
|
Retirement of Chairman
|
7 February 2022 at 10:20am
|